Foley & Larder LLP represented investor TCG Crossover. Silence Therapeutics plc (Nasdaq: SLN), an experienced and innovative biotechnology company committed to transforming people’s lives by silencing…
Silence Therapeutics’ $120 Million Private Placement
![](https://globallegalchronicle.com/wp-content/uploads/2024/02/silence-therapeutics-120-million-private-placement_65dd820c59f1a.jpeg)